Meqsel 0.5mg Tablet
Prescription Required
Product introduction
Meqsel 0.5mg Tablet is used alone or in combination with other medicines to treat skin cancer called as malignant melanoma.
Meqsel 0.5mg Tablet
Meqsel 0.5mg Tablet
Uses of Meqsel Tablet
Side effects of Meqsel Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Meqsel
- Rash
- Diarrhea
- Swelling of legs
- Swelling of hands
- Facial swelling
How to use Meqsel Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Meqsel 0.5mg Tablet is to be taken with food.
How Meqsel Tablet works
Meqsel 0.5mg Tablet is a kinase inhibitor. It works by blocking the activity of an abnormal protein that causes abnormal division of cancer cells.
Safety advice
Alcohol
There is no data available. Please consult doctor before consuming the drug.
Pregnancy
CONSULT YOUR DOCTOR
Meqsel 0.5mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Meqsel 0.5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Meqsel 0.5mg Tablet may cause side effects which could affect your ability to drive.
Patients should be made aware of potential for fatigue, dizziness, or eye problems that might affect the ability to drive or use machines.
Patients should be made aware of potential for fatigue, dizziness, or eye problems that might affect the ability to drive or use machines.
Kidney
There is no data available. Please consult doctor before consuming the drug.
Liver
There is no data available. Please consult doctor before consuming the drug.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Meqsel 0.5mg Tablet is used alone or in combination with another medicines to treat a type of skin cancer called melanoma.
- Take it on an empty stomach, at least 1 hour before or 2 hours after a meal.
- Use a reliable barrier contraceptive method such as condoms to prevent pregnancy while you are taking this medicine and for 4 months after you stop taking it.
- It may cause serious bleeding, especially in your stomach or brain. Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
- Get regular eye examinations while taking this medicine. Inform your doctor if you get eye irritation, blurred vision, eye pain or other vision changes during your treatment.
- Inform your doctor if you develop symptoms of liver damage such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
Fact Box
Chemical Class
Pyridopyrimidines
Habit Forming
No
Action Class
MEK inhibitor
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
- Medscape. Trametinib dimethyl sulfoxide. [Accessed 27 Mar. 2019] (online) Available from:
- Trametinib. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2014 [revised 14 Feb. 2019]. [Accessed 27 Mar. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: Switzerland
Lab tests offered by us
Related/Popular tests
234 people viewed this recentlyDISCONTINUED
We do not facilitate sale of this product at present